Pharmaceuticals and Blood Products Projects

AHA has conducted many projects in pharmaceutical and blood products sectors.  This includes our ongoing role as the Administration Agency for the CSO Funding Pool on behalf of the Department of Health and Ageing.  Our team members include pharmacists and consultants with a science background.
  
Examples of AHA's recent and current projects include:

• Administration Agency for the Community Service Obligation Funding Pool (DoHA)
  
• Price Disclosure Data Administrator (DoHA)
• Mid-point Review of Organ-Tissue Reform Package (OTA)
• Program Evaluation of the Haemophilia Foundation Australia (DoHA)
• Investigation of Comparative Demand Management Models (NBA)
• Section 100 Drug Review (DoHA)
• Review of pharmacy services for the Greater Southern Area Health Service (NSW Health)
• Economic analysis of Salmeterol for listing on the PBS (GlaxoSmithKline)
• Hospital Pharmaceutical Services Review for the Greater Western Area Health Services (NSW Health)
  
• Business Case for Expanding the Supply of Leucodepleted Fresh Blood Products in Australia (NBA)
• Cost Effectiveness of Intravenous Immunoglobulin (IVIg) Use in Australia (NBA)
• Benchmarking the Costs and Performance of the Production of Fresh Blood Products in Australia (NBA)
• Analysis of Haemovigilance Reporting Capacity (NBA)
• Independent Review of the National Cord Blood Network (DoHA)
  
• Evaluation of the Transfusion Nurse Program in Victoria (DHS)
• Review of the Key Structural Features of Selected Overseas and the Australian Organ and Tissue Donation Sectors (DoHA)
• Evaluation of the National Resource Centre administered by the Alcohol and Other Drug Council of Australia (DoHA)